Stemedica Announces the Appointment of Riccardo Nisato, MBA, PhD as Director of Manufacturing and Clinical Business Development for Stemedica Int... ( Stemedica Ce...)

HOME >> MEDICINE >> NEWS

Stemedica Announces the Appointment of Riccardo Nisato, MBA, PhD as Director of Manufacturing and Clinical Business Development for Stemedica International

Date:2/13/2009

Stemedica Cell Technologies, Inc., a leader in adult stem cell development, today announces that it has appointed Riccardo Nisato, MBA, PhD, as Director of Manufacturing and Clinical Business Development of Stemedica International, CH. Dr. Nisato will be responsible for replicating Stemedica's U.S. based operations to Stemedica's International's center based in Lausanne, Switzerland.

San Diego, Calif. (PRWEB) February 13, 2009 -- Stemedica Cell Technologies, Inc., a leader in adult stem cell development, today announces that it has appointed Riccardo Nisato, MBA, PhD, as Director of Manufacturing and Clinical Business Development of Stemedica International, CH. Dr. Nisato will be responsible for replicating Stemedica's U.S. based operations to Stemedica's International's center based in Lausanne, Switzerland.

A respected biologist, project leader and business consultant in the medical technology field, Dr. Nisato's specialty is the development of strategic options for cell therapy manufacturing that complies with Swiss Medic standards for Good Manufacturing Practice (GMP) in Switzerland. Dr. Nisato has a Master in Pharmacology from the University Paris V, a Ph.D. in Biology from the University of Geneva and an MBA in the Management of Technology from École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

"We are delighted to add Dr. Nisato to our Stemedica International team. Our plans to serve Clinical Research Centers outside the United States with in-depth stem cell research, product development, manufacturing and Master Bank product capabilities will be significantly advanced by Dr. Nisato's leadership and experience. His expertise in the cell manufacturing processes, incl
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)

Post Your Comments:

Stemedica Announces the Appointment of Riccardo Nisato, MBA, PhD as Director of Manufacturing and Clinical Business Development for Stemedica Int...( Stemedica Ce...),Health